| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/20/2014 | US8729076 Secondary 8-hydroxyquinoline-7-carboxamide derivatives |
| 05/20/2014 | US8729075 Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease |
| 05/20/2014 | US8729074 Inhibitors of PI3 kinase |
| 05/20/2014 | US8729073 5-methyl-1-(naphthalen-2-yl)-1H-pyrazole derivatives and their use in potentiating the effect of opioid analgesics |
| 05/20/2014 | US8729072 Alkylated piperazine compounds |
| 05/20/2014 | US8729071 Iminothiadiazine dioxide compounds as BACE inhibitors, compositions and their use |
| 05/20/2014 | US8729070 CNS pharmaceutical compositions and methods of use |
| 05/20/2014 | US8729069 Tetrahydropyridine, tetrahydroazepine, and dihydropyrrole derivatives for inflammation and immune-related uses |
| 05/20/2014 | US8729068 Tetrahydrobenzothiophene compound |
| 05/20/2014 | US8729067 Pharmacological treatment of cognitive impairment |
| 05/20/2014 | US8729066 1,2- bis-sulfonamide derivatives as chemokine receptor modulators |
| 05/20/2014 | US8729065 Crystalline forms of a pharmaceutical compound |
| 05/20/2014 | US8729064 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors |
| 05/20/2014 | US8729062 Benzyl azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators |
| 05/20/2014 | US8729061 Pyrrolidine derivatives |
| 05/20/2014 | US8729060 Macrocyclic polyoxazole compounds and use thereof |
| 05/20/2014 | US8729059 Paramyxovirus family inhibitors and methods of use thereof |
| 05/20/2014 | US8729058 Methods and compositions for treating and preventing viral infections |
| 05/20/2014 | US8729057 Testosterone gel and method of use |
| 05/20/2014 | US8729056 Preventive and/or therapeutic agent of hand-foot syndrome |
| 05/20/2014 | US8729055 Ursolic acid derivative and pharmaceutical composition thereof |
| 05/20/2014 | US8729054 3-desoxy-2-methylene-vitamin D analogs and their uses |
| 05/20/2014 | US8729053 Nuclear factor kappa B pathway inhibitor composition and use of same |
| 05/20/2014 | US8729051 Tri- and tetra-oligo-saccharides suitable as agglutination agents for enteric pathogens |
| 05/20/2014 | US8729050 Method for prevention and treatment of reflux injury in the aerodigestive tract and laryngopharynx caused by pepsin |
| 05/20/2014 | US8729049 Leaven-based mixture |
| 05/20/2014 | US8729048 Methods and materials for assessing responsiveness to PARP inhibitors and platinating agents |
| 05/20/2014 | US8729047 Compositions for inhibiting redox-sensitive GTPases |
| 05/20/2014 | US8729039 Use of inhibitory oligonucleotides to treat autoimmune disease |
| 05/20/2014 | US8729037 Method and medicament for inhibiting the expression of a given gene |
| 05/20/2014 | US8729036 Compositions for RNA interference and methods of use thereof |
| 05/20/2014 | US8729035 Synthesis of novel neamine derivatives and use thereof as antibacterial agents |
| 05/20/2014 | US8729034 Pharmaceutical composition having virucidal and spermicidal activity |
| 05/20/2014 | US8729033 Therapeutic, dietary or cosmetic use of compounds with specific anti-apoptotic activity toward caspase-3, and compositions containing these compounds |
| 05/20/2014 | US8729026 Method for inhibiting autophagy of motor neurons |
| 05/20/2014 | US8728978 Biocide compositions (IV) |
| 05/20/2014 | US8728797 Yeast membrane protein expression system and its application in drug screening |
| 05/20/2014 | US8728796 Tiacumicin production |
| 05/20/2014 | US8728553 Vitamin containing product |
| 05/20/2014 | US8728535 Nutritional supplement for use under physiologically stressful conditions |
| 05/20/2014 | US8728531 Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (LDL) per-oxidation in humans |
| 05/20/2014 | US8728524 Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions |
| 05/20/2014 | US8728522 Pharmaceutical compositions for treating or preventing pain |
| 05/20/2014 | US8728517 Pharmaceutical compositions of entacapone co-micronized with sugar alcohols |
| 05/20/2014 | US8728511 Method of treatment comprising administering controlled release melatonin |
| 05/20/2014 | US8728510 Biocompatible carrier containing a bioadhesive material |
| 05/20/2014 | US8728507 Non-systemic control of parasites |
| 05/20/2014 | US8728506 Durable pest repellent and pest repellent resin composition |
| 05/20/2014 | US8728504 Process for solubilizing hydrophobic active ingredients in aqueous medium |
| 05/20/2014 | US8728493 Polymer based compositions and conjugates of non-steroidal anti-inflammatory drugs |
| 05/20/2014 | US8728488 Methods of inducing an immune response in a host by administering flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens |
| 05/20/2014 | US8728476 Compositions and methods to enhance the immune system |
| 05/20/2014 | US8728474 Immunopotentiative composition |
| 05/20/2014 | US8728453 Combinatorial polymeric compositions for drug delivery |
| 05/20/2014 | US8728444 Formulation comprising nicotine and a cation exchange resin |
| 05/20/2014 | US8728443 Formulation comprising nicotine and a cation exchange resin |
| 05/20/2014 | US8728441 Sublingual buccal effervescent |
| 05/20/2014 | US8727988 Tissue penetrating catheters having integral imaging transducers and their methods of use |
| 05/20/2014 | CA2770509C Silicone modified fatty acids, method of preparation and usage thereof |
| 05/20/2014 | CA2716893C Use of s-adenosylmethionine (sam) and superoxide dismutase (sod) for the preparation of medicaments for the treatment of alzheimer's disease |
| 05/20/2014 | CA2703834C Silibinin component for the treatment of hepatitis |
| 05/20/2014 | CA2670340C Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators |
| 05/20/2014 | CA2634379C Treatment of type 2 diabetes with a combination of dpiv inhibitor and metformin or thiazolidinedione |
| 05/20/2014 | CA2626636C Method for stimulating intestinal barrier integrity after non-natural birth |
| 05/20/2014 | CA2624882C Pyrazolopyrimidines as protein kinase inhibitors |
| 05/20/2014 | CA2624588C Anticoagulant antithrombotic dual inhibitors comprising a biotin label |
| 05/20/2014 | CA2621503C Triazole derivatives useful as axl inhibitors |
| 05/20/2014 | CA2621441C Compositions and methods for the diagnosis and therapy of bcl2-associated cancers |
| 05/20/2014 | CA2621261C Azepine inhibitors of janus kinases |
| 05/20/2014 | CA2612482C Biologically active compounds obtainable from sorangium cellulosum |
| 05/20/2014 | CA2599712C Folic acid-, vitamin b6- and vitamin b12-containing agents and the use thereof |
| 05/20/2014 | CA2598416C Kappa opioid receptor ligands |
| 05/20/2014 | CA2591399C Aminocarboxylic acid derivative and medicinal use thereof |
| 05/20/2014 | CA2589638C 7-membered ring compound and method of production and pharmaceutical application thereof |
| 05/20/2014 | CA2519023C Facially amphiphilic polymers and oligomers and uses thereof |
| 05/20/2014 | CA2518513C N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses |
| 05/20/2014 | CA2497060C Aryl and heteroaryl propene amides, derivatives thereof and therapeutic uses thereof |
| 05/20/2014 | CA2471504C Ligand for g-protein coupled receptor gpr43 and uses thereof |
| 05/20/2014 | CA2448567C Modulators of nucleic acid ligands |
| 05/15/2014 | WO2014075093A1 Inhibitors of central nervous system vasoactive inhibitory peptide receptor 2 |
| 05/15/2014 | WO2014075082A1 Disease severity index for assessment of chronic liver disease and method for diagnosis of three distinct subtypes of primary sclerosing cholangitis |
| 05/15/2014 | WO2014075077A1 Certain chemical entities, compositions, and methods |
| 05/15/2014 | WO2014074997A1 Enzymes for inhibiting growth of biofilms and degrading same |
| 05/15/2014 | WO2014074976A1 Compositions and methods for treating neurological diseases or injury |
| 05/15/2014 | WO2014074952A1 Methods and compositions for localized delivery of agents to hiv-infected cells and tissues |
| 05/15/2014 | WO2014074940A1 Crystalline forms of (1s)-1-[5-({3-[(2-methylpyridin-3-yl)oxy]-5-(pyridin-2-ylsulfanyl)pyridin-2-yl}amino)-1,2,4-thiadiazol-3-yl]ethane-1,2-diol |
| 05/15/2014 | WO2014074932A1 Antimicrobial agents |
| 05/15/2014 | WO2014074926A1 Therapeutic hydroxyquinolones |
| 05/15/2014 | WO2014074848A1 Therapeutic compounds and compositions and their use as pkm2 modulators |
| 05/15/2014 | WO2014074846A1 Methods for the treatment of bone loss |
| 05/15/2014 | WO2014074815A1 Small molecule inhibitors of malt1 |
| 05/15/2014 | WO2014074795A1 High dose levodopa capsules for pulmonary use |
| 05/15/2014 | WO2014074778A1 Aryl derivatives and uses thereof |
| 05/15/2014 | WO2014074775A1 Heteroaryl derivatives and uses thereof |
| 05/15/2014 | WO2014074765A2 Vitamin c, vitamin k, a polyphenol, and combinations thereof for wound healing |
| 05/15/2014 | WO2014074761A2 Novel compounds as diacylglycerol acyltransferase inhibitors |
| 05/15/2014 | WO2014074753A1 Oral care composition containing theaflavin extract |
| 05/15/2014 | WO2014074744A1 X-ray contrast media compositions and methods of using the same to treat inflammation associated conditions |
| 05/15/2014 | WO2014074734A1 Method for regulating retinal endothelial cell viability |
| 05/15/2014 | WO2014074725A1 Substituted gemcitabine aryl amide analogs |